Healthtech Investors & VC Firms in North America

2650 firms in this list, with a median first check of $500K. 645 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
BI BioHealth Innovation, Inc. RBAMCBCC23 people	88🔒	Rockville	US	—	—	+ Add to CRM
WE Westlake Village BioPartners BSDAMCSH11 people · Follows rounds	88🔒	Los Angeles	US	Pre-Seed–Series A	$100K – $5M	+ Add to CRM
IM Immeasurable BV1 person	88🔒	Los Angeles	US	Pre-Seed–Seed	$25K – $100K	+ Add to CRM
MU Munich Re Ventures SACMJTAR4 people · Follows rounds	88🔒	San Francisco	US	Seed–Series B	—	+ Add to CRM
VE Vetted Accelerator AWNGYDBG25 people	88🔒	Miami	US	Pre-Seed–Seed	—	+ Add to CRM
CA Carbide Ventures KHBTDWHY9 people	88🔒	Palo Alto	US	Pre-Seed–Series A	—	+ Add to CRM
HE HealthQuest Capital GKRSDKJT12 people	88🔒	Redwood City	US	Growth–Late Stage	—	+ Add to CRM
RE REMUS Capital KKJTJRSP9 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series B	$25K – $20M	+ Add to CRM
DI Divergent Capital KSLWGMKS8 people · Leads rounds	88🔒	New York	US	Pre-Seed–Seed	$250K – $1M	+ Add to CRM
GE GE Ventures KKBCLBLC8 people · Leads rounds	88🔒	Cincinnati	US	Pre-Seed–Seed	—	+ Add to CRM
IN Ingeborg Investments OWAMMKCF5 people	88🔒	Bentonville	US	Pre-Seed–Seed	—	+ Add to CRM
AX Axial VC JERP2 people · Follows rounds	88🔒	San Francisco	US	Pre-Seed–Seed	$100K – $5M	+ Add to CRM
GE Genstar TC1 person · Leads rounds	88🔒	San Francisco	US	Growth	—	+ Add to CRM
MO Mountain Group Capital BSJCJCRR13 people	88🔒	Nashville	US	Pre-Seed–Seed	—	+ Add to CRM
CO Cowles Ventures BCSCBGMN9 people	88🔒	Spokane	US	Seed–Series A	$250K – $1M	+ Add to CRM
GR Gryphon	88🔒	San Francisco	US	—	—	+ Add to CRM
IA Iaso Ventures WQJRMGMF15 people	88🔒	Cambridge	US	Seed–Series A	—	+ Add to CRM
SW Switch Ventures BGMGPAAH9 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series A	—	+ Add to CRM
CY Cybernetix Ventures FSMMSFAS17 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series A	$60K – $500K	+ Add to CRM
IM Impact America Fund KCYSDCFG11 people · Follows rounds	88🔒	Irvine	US	Seed–Series B	$250K – $3M	+ Add to CRM
IN Innospark Ventures MKDVDVMF11 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Series A	$2M	+ Add to CRM
NV NVP Capital DBVCSDDK8 people · Leads rounds	88🔒	New York	US	Pre-Seed–Seed	$2M	+ Add to CRM
TO Toronto Innovation Acceleration Partners BGCADRDA11 people	88🔒	Toronto	CA	Pre-Seed–Seed	—	+ Add to CRM
VA VamosVentures AMARMGAG11 people · Leads rounds	88🔒	Los Angeles	US	Pre-Seed–Series A	$2M	+ Add to CRM

BioHealth Innovation, Inc.

Rockville

RBAMCBCC23 people

Westlake Village BioPartners

Los AngelesPre-Seed–Series A$100K – $5M

BSDAMCSH11 people

Immeasurable

Los AngelesPre-Seed–Seed$25K – $100K

BV1 person

Munich Re Ventures

San FranciscoSeed–Series B

SACMJTAR4 people

Vetted Accelerator

MiamiPre-Seed–Seed

AWNGYDBG25 people

Carbide Ventures

Palo AltoPre-Seed–Series A

KHBTDWHY9 people

HealthQuest Capital

Redwood CityGrowth–Late Stage

GKRSDKJT12 people

REMUS Capital

BostonPre-Seed–Series B$25K – $20M

KKJTJRSP9 people

Divergent Capital

New YorkPre-Seed–Seed$250K – $1M

KSLWGMKS8 people

GE Ventures

CincinnatiPre-Seed–Seed

KKBCLBLC8 people

Ingeborg Investments

BentonvillePre-Seed–Seed

OWAMMKCF5 people

Axial VC

San FranciscoPre-Seed–Seed$100K – $5M

JERP2 people

Genstar

San FranciscoGrowth

TC1 person

Mountain Group Capital

NashvillePre-Seed–Seed

BSJCJCRR13 people

Cowles Ventures

SpokaneSeed–Series A$250K – $1M

BCSCBGMN9 people

Gryphon

San Francisco

Iaso Ventures

CambridgeSeed–Series A

WQJRMGMF15 people

Switch Ventures

San FranciscoPre-Seed–Series A

BGMGPAAH9 people

Cybernetix Ventures

BostonPre-Seed–Series A$60K – $500K

FSMMSFAS17 people

Impact America Fund

IrvineSeed–Series B$250K – $3M

KCYSDCFG11 people

Innospark Ventures

BostonPre-Seed–Series A$2M

MKDVDVMF11 people

NVP Capital

New YorkPre-Seed–Seed$2M

DBVCSDDK8 people

Toronto Innovation Acceleration Partners

TorontoPre-Seed–Seed

BGCADRDA11 people

VamosVentures

Los AngelesPre-Seed–Series A$2M

AMARMGAG11 people

Data sourced from public filings and firms' own websites — see our methodology.